145 Characterization of Adverse Reactions in Patients with Advanced Endometrial Cancer (Aec) Receiving Lenvatinib + Pembrolizumab (Study 309/Keynote-775)

AuthID
P-00V-TAT
19
Author(s)
Colombo, N
·
Lorusso, D
·
Santin, A
·
Kim, Y
·
Herráez, A
·
Yonemori, K
·
Fujiwara, K
·
Colomba, E
·
Pignata, S
·
Monk, B
·
Guerra, E
·
Kristeleit, R
·
Orlando, M
·
Sanli, U
·
Dutta, L
·
Orlowski, R
·
Ren, M
·
Makker, V
Tipo de Documento
Proceedings Paper
Year published
2021
Publicado
in Endometrial cancer
Indexing
Publication Identifiers
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.